S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
The single greatest medical breakthrough of all time? (Ad)
How major US stock indexes fared Friday 6/9/2023
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
The single greatest medical breakthrough of all time? (Ad)
MarketBeat Week in Review – 6/4 - 6/9
New Mexico reaches $500M settlement with Walgreens in opioid case
The single greatest medical breakthrough of all time? (Ad)
Mark Zuckerberg Delivers Dorky Diss of Apple's Pricey New Headset
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
NASDAQ:SEEL

Seelos Therapeutics (SEEL) Price Target & Analyst Ratings

$0.92
0.00 (0.00%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.87
▼
$0.94
50-Day Range
$0.66
▼
$1.06
52-Week Range
$0.58
▼
$1.52
Volume
513,552 shs
Average Volume
471,492 shs
Market Capitalization
$111.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Seelos Therapeutics Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

$3.33
264.30% Upside
High Prediction$4.00
Average Prediction$3.33
Low Prediction$2.00
TypeCurrent
6/10/22 to 6/10/23		1 Month Ago
5/11/22 to 5/11/23		3 Months Ago
3/12/22 to 3/12/23		1 Year Ago
6/10/21 to 6/10/22
Consensus RatingN/A
Buy
Buy
Buy
Strong Buy N/A
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy N/A
1 Buy rating(s)
2 Buy rating(s)
4 Buy rating(s)
Hold N/A
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell N/A
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$3.33$4.00$4.00$6.67
Predicted Upside264.30% Upside478.12% Upside334.78% Upside253.98% Upside
Get Seelos Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SEEL and its competitors with MarketBeat's FREE daily newsletter.


SEEL Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SEEL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Seelos Therapeutics Stock vs. The Competition

TypeSeelos TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
0.00
2.66
2.48
Consensus RatingN/ABuyHold
Predicted Upside264.30% Upside1,154.47% Upside247.62% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/16/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$3.00 ➝ $2.00+120.07%
5/15/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$11.00 ➝ $4.00+346.28%
3/24/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$6.00 ➝ $4.00+478.11%
(Data available from 6/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SEEL Price Target - Frequently Asked Questions

Does Seelos Therapeutics's stock price have much upside?

According to analysts, Seelos Therapeutics's stock has a predicted upside of 300.48% based on their 12-month price targets.

What analysts cover Seelos Therapeutics?

Seelos Therapeutics has been rated by Benchmark, BTIG Research, and Cantor Fitzgerald in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:SEEL) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -